Using lifetime risk estimates to recommend magnetic resonance imaging screening for breast cancer survivors.
作者信息
Punglia Rinaa S, Hassett Michael J
机构信息
Dana-Farber Cancer Institute, Brigham & Women's Hospital, and Harvard Medical School, Boston, MA, USA.
出版信息
J Clin Oncol. 2010 Sep 20;28(27):4108-10. doi: 10.1200/JCO.2010.30.0350. Epub 2010 Aug 9.
Abstract
摘要
相似文献
1
Using lifetime risk estimates to recommend magnetic resonance imaging screening for breast cancer survivors.
J Clin Oncol. 2010 Sep 20;28(27):4108-10. doi: 10.1200/JCO.2010.30.0350. Epub 2010 Aug 9.
2
Mammography surveillance and mortality in older breast cancer survivors.
J Clin Oncol. 2007 Jul 20;25(21):3001-6. doi: 10.1200/JCO.2006.09.9572. Epub 2007 Jun 4.
3
Utility of surveillance MRI in women with a personal history of breast cancer.
Clin Imaging. 2017 Nov-Dec;46:33-36. doi: 10.1016/j.clinimag.2017.06.007. Epub 2017 Jul 3.
4
Diagnosis of second breast cancer events after initial diagnosis of early stage breast cancer.
Breast Cancer Res Treat. 2010 Dec;124(3):863-73. doi: 10.1007/s10549-010-1106-6. Epub 2010 Aug 11.
5
Magnetic resonance imaging screening of the contralateral breast in women with newly diagnosed breast cancer: systematic review and meta-analysis of incremental cancer detection and impact on surgical management.
J Clin Oncol. 2009 Nov 20;27(33):5640-9. doi: 10.1200/JCO.2008.21.5756. Epub 2009 Oct 5.
6
[Concealed local recurrence after breast-conserving treatment].
Ned Tijdschr Geneeskd. 2002 Oct 12;146(41):1959-60; author reply 1960.
7
Breast cancer imaging--what are the optimal modalities?
Eur J Surg Oncol. 1998 Dec;24(6):573-82. doi: 10.1016/s0748-7983(98)93824-0.
8
Are short-term or long-term recurrence rates more important in breast cancer screening?
Ann Intern Med. 2008 Sep 2;149(5):357; author reply 357-8. doi: 10.7326/0003-4819-149-5-200809020-00014.
9
Screening for second cancers and osteoporosis in long-term survivors.
Cancer Pract. 2000 Nov-Dec;8(6):282-90. doi: 10.1046/j.1523-5394.2000.86008.x.
10
Breast cancer: The importance of overdiagnosis in breast-cancer screening.
Nat Rev Clin Oncol. 2016 Jan;13(1):5-6. doi: 10.1038/nrclinonc.2015.203. Epub 2015 Nov 17.
引用本文的文献
1
MR-contrast enhanced mammography (CEM) for follow-up of breast cancer patients: a "pros and cons" debate.
Eur Radiol. 2024 Oct;34(10):6264-6270. doi: 10.1007/s00330-024-10684-w. Epub 2024 Mar 15.
2
Overview in Breast Cancer Screening in Lebanon.
Cancer Control. 2021 Jan-Dec;28:10732748211039443. doi: 10.1177/10732748211039443.
3
Magnetic Resonance Imaging in Screening of Breast Cancer.
Radiol Clin North Am. 2021 Jan;59(1):85-98. doi: 10.1016/j.rcl.2020.09.004. Epub 2020 Oct 29.
4
Development and Implementation of an Algorithm to Guide MRI Screening in Patients With a Personal History of Treated Breast Cancer.
Clin Breast Cancer. 2021 Feb;21(1):26-30. doi: 10.1016/j.clbc.2020.01.005. Epub 2020 Oct 17.
5
Surveillance for second breast cancer events in women with a personal history of breast cancer using breast MRI: a systematic review and meta-analysis.
Breast Cancer Res Treat. 2020 Jun;181(2):255-268. doi: 10.1007/s10549-020-05637-y. Epub 2020 Apr 17.
6
Breast Cancer Screening With Mammography Plus Ultrasonography or Magnetic Resonance Imaging in Women 50 Years or Younger at Diagnosis and Treated With Breast Conservation Therapy.
JAMA Oncol. 2017 Nov 1;3(11):1495-1502. doi: 10.1001/jamaoncol.2017.1256.
7
Risk factors for second screen-detected or interval breast cancers in women with a personal history of breast cancer participating in mammography screening.
Cancer Epidemiol Biomarkers Prev. 2013 May;22(5):946-61. doi: 10.1158/1055-9965.EPI-12-1208-T. Epub 2013 Mar 19.
8
Accuracy and outcomes of screening mammography in women with a personal history of early-stage breast cancer.
JAMA. 2011 Feb 23;305(8):790-9. doi: 10.1001/jama.2011.188.
本文引用的文献
1
Screening for breast cancer with mammography.
Cochrane Database Syst Rev. 2009 Oct 7(4):CD001877. doi: 10.1002/14651858.CD001877.pub3.
2
Prevalence of breast carcinoma in situ in the United States.
JAMA. 2009 Aug 26;302(8):846-8. doi: 10.1001/jama.2009.1211.
3
Cost effectiveness of breast cancer screening with contrast-enhanced MRI in high-risk women.
J Am Coll Radiol. 2009 Mar;6(3):171-9. doi: 10.1016/j.jacr.2008.10.003.
4
Breast cancer survivors in the United States: geographic variability and time trends, 2005-2015.
Cancer. 2009 May 1;115(9):1954-66. doi: 10.1002/cncr.24217.
5
Breast cancer. Clinical practice guidelines in oncology.
J Natl Compr Canc Netw. 2009 Feb;7(2):122-92. doi: 10.6004/jnccn.2009.0012.
6
Cost-effectiveness of MRI compared to mammography for breast cancer screening in a high risk population.
BMC Health Serv Res. 2009 Jan 13;9:9. doi: 10.1186/1472-6963-9-9.
7
Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer.
Ann Intern Med. 2008 May 6;148(9):671-9. doi: 10.7326/0003-4819-148-9-200805060-00007.
8
United States life tables, 2004.
Natl Vital Stat Rep. 2007 Dec 28;56(9):1-39.
9
Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials.
Lancet. 2008 Jan 5;371(9606):29-40. doi: 10.1016/S0140-6736(08)60069-0.
10
Mammography surveillance and mortality in older breast cancer survivors.
J Clin Oncol. 2007 Jul 20;25(21):3001-6. doi: 10.1200/JCO.2006.09.9572. Epub 2007 Jun 4.
Zotero 插件